Pro-oxidant diet enhances β/γ secretase-mediated APP processing in APP/PS1 transgenic mice

Neurobiology of Aging

Volumn 33, Issue 5, 2012, Pages 960-968

  Choudhry, Fahd ^a   Howlett, David R ^a,b   Richardson, Jill C ^b   Francis, Paul T ^a   Williams, Robert J ^a,c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

Alzheimer's disease; APP; BACE; Oxidative stress; Presenilin; TASTPM mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; BETA SECRETASE 1; CARBONYL DERIVATIVE; GAMMA SECRETASE; GLUTATHIONE; PRESENILIN 1; TRANSCRIPTION FACTOR NRF2;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN LEVEL; BRAIN NERVE CELL; BRAIN TISSUE; CONTROLLED STUDY; DIETARY INTAKE; ENZYME ACTIVITY; MOUSE; NEUROPATHOLOGY; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROCESSING; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; AMYLOID PRECURSOR PROTEIN SECRETASES; ANIMAL FEED; ANIMALS; ASPARTIC ACID ENDOPEPTIDASES; HUMANS; MICE; MICE, TRANSGENIC; OXIDANTS; OXIDATIVE STRESS; PRESENILIN-1; PRIMARY CELL CULTURE; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84858335388     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.07.008     Document Type: Article

References (37)

1. Bahia P.K., Rattray M., Williams R.J. Dietary flavonoid (-)epicatechin stimulates phosphatidylinositol 3-kinase-dependent anti-oxidant response element activity and up-regulates glutathione in cortical astrocytes. J. Neurochem. 2008, 106:2194-2204.
2. Behl C. Alzheimer's disease and oxidative stress: implications for novel therapeutic approaches. Prog. Neurobiol. 1999, 57:301-323.
3. Borghi R., Patriarca S., Traverso N., Piccini A., Storace D., Garuti A., Cirmena G., Odetti P., Tabaton M. The increased activity of BACE1 correlates with oxidative stress in Alzheimer's disease. Neurobiol. Aging 2007, 28:1009-1014.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
5. Dai Q., Borenstein A.R., Wu Y.G., Jackson J.C., Larson E.B. Fruit and vegetable juices and Alzheimer's disease: The Kame Project. Am. J. Med. 2006, 119:751-759.
6. Esposito L., Raber J., Kekonius L., Yan F.R., Yu G.Q., Bien-Ly N., Puolivali J., Scearce-Levie K., Masliah E., Mucke L. Reduction in mitochondrial superoxide dismutase modulates Alzheimer's disease-like pathology and accelerates the onset of behavioral changes in human amyloid precursor protein transgenic mice. J. Neurosci. 2006, 26:5167-5179.
7. Furuta A., Price D.L., Pardo C.A., Troncoso J.C., Xu Z.S., Taniguchi N., Martin L.J. Localization of superoxide dismutases in Alzheimer's disease and Down's syndrome neocortex and hippocampus. Am. J. Pathol. 1995, 146:357-367.
8. Giliberto L., Borghi R., Piccini A., Mangerini R., Sorbi S., Cirmena G., Garuti A., Ghetti B., Tagliavini F., Mughal M.R., Mattson M.P., Zhu X., Wang X., Guglielmotto M., Tamagno E., Tabaton M. Mutant presenilin 1 increases the expression and activity of BACE1. J. Biol. Chem. 2009, 284:9027-9038.
9. Hoey S.E., Williams R.J., Perkinton M.S. Synaptic NMDA Receptor Activation Stimulates alpha-Secretase APP Processing and Inhibits Amyloid-beta Production. J. Neurosci. 2009, 29:4442-4460.
10. Howlett D.R., Richardson J.C. The pathology of APP transgenic mice: a model of Alzheimer's disease or simply overexpression of APP?. Histol. Histopathol. 2009, 24:83-100.
11. Howlett D.R., Richardson J.C., Austin A., Parsons A.A., Bate S.T., Davies D.C., Gonzalez M.I. Cognitive correlates of Abeta deposition in male and female mice bearing amyloid precursor protein and presenilin-1 mutant transgenes. Brain Res. 2004, 1017:130-136.
12. Hussain I., Hawkins J., Harrison D., Hille C., Wayne G., Cutler L., Buck T., Walter D., Demont E., Howes C., Naylor A., Jeffrey P., Gonzalez M.I., Dingwall C., Michel A., Redshaw S., Davis J.B. Oral administration of a potent and selective non-peptidic BACE-1 inhibitor decreases beta-cleavage of amyloid precursor protein and amyloid-beta production in vivo. J. Neurochem. 2007, 100:802-809.
13. Izumi R., Yamada T., Yoshikai S., Sasaki H., Hattori M., Sakaki Y. Positive and negative regulatory elements for the expression of the Alzheimer's disease amyloid precursor-encoding gene in mouse. Gene 1992, 112:189-195.
14. Johnson J.A., Johnson D.A., Kraft A.D., Calkins M.J., Jakel R.J., Vargas M.R., Chen P.C. The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration. Ann. N.Y. Acad. Sci. 2008, 1147:61-69.
15. Jin S.M., Cho H.J., Jung E.S., Shim M.Y., Mook-Jung I. mage-inducing agents elicit gamma-secretase activation mediated by oxidative stress. Cell Death Differ. 2008, 15:1375-1384.
16. Kanninen K., Malm T.M., Jyrkkänen H.K., Goldsteins G., Keksa-Goldsteine V., Tanila H., Yamamoto M., Ylä-Herttuala S., Levonen A.L., Koistinaho J. r factor erythroid 2-related factor 2 protects against beta amyloid. Mol. Cell. Neurosci. 2008, 39:302-313.
17. Kuriyama S., Hozawa A., Ohmori K., Shimazu T., Matsui T., Ebihara S., Awata S., Nagatomi R., Arai H., Tsuji I. Green tea consumption and cognitive function: a cross-sectional study from the Tsurugaya Project. 1. Am. J. Clin. Nutr 2006, 83:355-361.
18. Lahiri D.K., Ge Y.W., Maloney B. Characterization of the APP proximal promoter and 5'-untranslated regions: identification of cell-type specific domains and implications in APP gene expression and Alzheimer's disease. FASEB J. 2005, 19:653-655.
19. Markesbery W.R., Lovell M.A. Damage to lipids, proteins, DNA and RNA in mild cognitive impairment. Arch. Neurol. 2007, 64:954-956.
20. Molina-Holgado F., Hider R.C., Gaeta A., Williams R., Francis P. Metals ions and neurodegeneration. Biol. Met. 2007, 20:639-654.
21. Moreira P.I., Nunomura A., Nakamura M., Takeda A., Shenk J.C., Aliev G., Smith M.A., Perry G. Nucleic acid oxidation in Alzheimer disease. Free Radic. Biol. Med. 2008, 44:1493-1505.
22. Morris R. Thy-1 in developing nervous tissue. Dev. Neurosci. 1985, 7:133-160.
23. Nunomura A., Perry G., Pappolla M.A., Friedland R.P., Hirai K., Chiba S., Smith M.A. Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome. J. Neuropathol. Exp. Neurol. 2000, 59:1011-1017.
24. Nunomura A., Perry G., Pappolla M.A., Wade R., Hirai K., Chiba S., Smith M.A. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease. J. Neurosci. 1999, 19:1959-1964.
25. Pike C.J., Burdick D., Walencewicz A.J., Glabe C.G., Cotman C.W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J. Neurosci. 1993, 13:1676-1687.
26. Powers K.M., Smith-Weller T., Franklin G.M., Longstreth W.T., Swanson P.D., Checkoway H. Parkinson's disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 2003, 60:1761-1766.
27. Praticò D., Uryu K., Leight S., Trojanowski J.Q., Lee V.M.Y. Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis. J. Neurosci. 2001, 21:4183-4187.
28. Praticò D. Evidence of oxidative stress in Alzheimer's disease brain and antioxidant therapy: lights and shadows. Ann. N.Y. Acad. Sci. 2008, 1147:70-78.
29. Reddy V.P., Zhu X., Perry G., Smith M.A. Oxidative stress in diabetes and Alzheimer's disease. J. Alzheimers Dis. 2009, 16:763-774.
30. Rogers J.T., Randall J.D., Cahill C.M., Eder P.S., Huang X., Gunshin H., Leiter L., McPhee J., Sarang S.S., Utsuki T., Greig N.H., Lahiri D.K., Tanzi R.E., Bush A.I., Giordano T., Gullans S.R. An iron-responsive element type II in the 5'-untranslated region of the Alzheimer's amyloid precursor protein transcript. J. Biol. Chem. 2002, 277:45518-45528.
31. Selkoe D.J. Alzheimer's disease: genes, proteins, and therapy. Physiol. Res. 2001, 81:741-766.
32. Shen C.Y., Chen Y.F., Liu H.Q., Zhang K.J., Zhang T., Lin A., Jing N.H. Hydrogen peroxide promotes Abeta production through JNK-dependent activation of gamma-secretase. J. Biol. Chem. 2008, 283:17721-17730.
33. Shineman D.W., Zhang B., Leight S.N., Pratico D., Lee V.M. Thromboxane receptor activation mediates isoprostane-induced increases in amyloid pathology in Tg2576 mice. J. Neurosci. 2008, 28:4785-4794.
34. Sultana R., Perluigi M., Butterfield D.A. Oxidatively modified proteins in Alzheimer's Disease (AD), mild cognitive impairment and animal models of AD: role in Abeta pathogenesis. Acta Neuropathol. 2009, 118:131-150.
35. Tamagno E., Bardini P., Obbili A., Vitali A., Borghi R., Zaccheo D., Pronzato M.A., Danni O., Smith M.A., Perry G., Tabaton M. Oxidative stress increases expression and activity of BACE in NT2 neurons. Neurobiol. Dis. 2002, 10:279-288.
36. Tamagno E., Guglielmotto M., Aragno M., Borghi R., Autelli R., Giliberto L., Muraca G., Danni O., Zhu X., Smith M.A., Perry G., Jo D.G., Mattson M.P., Tabaton M. Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J. Neurochem. 2008, 104:683-695.
37. Tong Y., Zhou W., Fung V., Christensen M.A., Qing H., Sun X., Song W. Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Trans 2005, 112:455-469.